Last reviewed · How we verify
NCT05754268: CSRAS
Establishment, Verification and Clinical Application of Chinese Version of Surgical Risk Assessment System
trial testing Chinese version of the surgical risk assessment system in Risk Assessment in 10,000 participants. Status unknown.
31 August 2024
Quick facts
| Lead sponsor | luyun |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 10,000 |
| Start date | 1 January 2022 |
| Primary completion | 31 August 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Chinese version of the surgical risk assessment system
Conditions studied
- Risk Assessment — all drugs for Risk Assessment →
- Risk Factors — all drugs for Risk Factors →
- Machine Learning — all drugs for Machine Learning →
- Artificial Intelligence — all drugs for Artificial Intelligence →
Sponsor
luyun
Who can join
Eligibility, any sex, with Risk Assessment or Risk Factors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to establish and verify the Chinese version of surgical risk assessment system and explore its clinical application. The main questions it aims to answer are: The process of establishing a Chinese version of surgical risk assessment system; What is the accuracy of the system; How can the system be used in clinic; How does this system compare with other systems (such as NSQIP). Participants will comprehensively collect the general information, examination and pathological information of the patients, using machine learning and artificial intelligence methods for data processing. Finally, the Chinese version of the surgical risk assessment system will be established. After the system is established, investigators will evaluate the accuracy of the system and compare it with other related systems.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05754268
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Risk Assessment
Currently open trials in the same condition.
- NCT07129616 — Remote Monitoring of Asthma in Children and Young People · recruiting
- NCT07287280 — Comparing CCI and POSSUM for Predicting Oncogynecologic Surgery Complications · recruiting
- NCT06740773 — Risk Factors for Complications After Cranioplasty · recruiting
- NCT07527715 — Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05754268 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by luyun
- Last refreshed: 7 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05754268.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing